Clinical nutrition, body composition and oncology: a critical literature review of the synergies.

作者: Nathalie Jacquelin-Ravel , Claude Pichard

DOI: 10.1016/J.CRITREVONC.2012.02.001

关键词: Composition (language)DosingOncologyWastingWeight lossTherapeutic approachBody surface areaMedicineCachexiaInternal medicineClinical nutrition

摘要: Abstract Purpose of the research Review oncology and clinical nutrition literature to highlight synergies between those two subjects. This review focuses on diagnostic lean body wasting recent improvements in measuring composition monitor response during optimal treatment. Principal results Nutrition support cancer patients has made major progresses. A variety advanced tools allow monitoring explaining weight loss, changes metabolic alterations. Body is more accurate than surface area determine chemotherapeutic drug dosing. As with any therapeutic approach, a better risk-benefit ratio if implemented when indicated rather used routinely. measurements are helpful for understanding host-tumor interactions treatment support. Major conclusions based analysis may significantly contribute optimize current outcomes.

参考文章(57)
Pierre Singer, Mette M. Berger, Greet Van den Berghe, Gianni Biolo, Philip Calder, Alastair Forbes, Richard Griffiths, Georg Kreyman, Xavier Leverve, Claude Pichard, ESPEN Guidelines on Parenteral Nutrition: intensive care. Clinical Nutrition. ,vol. 28, pp. 387- 400 ,(2006) , 10.1016/J.CLNU.2009.04.024
Mellar P. Davis, Tugba Yavuzsen, Dilara Khoshknabi, Jordanka Kirkova, Declan Walsh, Wael Lasheen, Ruth Lagman, Matthew T. Karafa, Bioelectrical impedance phase angle changes during hydration and prognosis in advanced cancer. American Journal of Hospice and Palliative Medicine. ,vol. 26, pp. 180- 187 ,(2009) , 10.1177/1049909108330028
Digant Gupta, Carolyn A Lammersfeld, Pankaj G Vashi, Jessica King, Sadie L Dahlk, James F Grutsch, Christopher G Lis, Bioelectrical impedance phase angle in clinical practice: implications for prognosis in stage IIIB and IV non-small cell lung cancer. BMC Cancer. ,vol. 9, pp. 37- 37 ,(2009) , 10.1186/1471-2407-9-37
Richard J.E. Skipworth, Grant D. Stewart, Cornelis H.C. Dejong, Tom Preston, Kenneth C.H. Fearon, Pathophysiology of cancer cachexia: Much more than host–tumour interaction? Clinical Nutrition. ,vol. 26, pp. 667- 676 ,(2007) , 10.1016/J.CLNU.2007.03.011
Benjamin HL Tan, Kenneth CH Fearon, Cachexia: prevalence and impact in medicine. Current Opinion in Clinical Nutrition and Metabolic Care. ,vol. 11, pp. 400- 407 ,(2008) , 10.1097/MCO.0B013E328300ECC1
P. Irigaray, J.A. Newby, S. Lacomme, D. Belpomme, Overweight/obesity and cancer genesis: more than a biological link. Biomedicine & Pharmacotherapy. ,vol. 61, pp. 665- 678 ,(2007) , 10.1016/J.BIOPHA.2007.10.008
William J. Evans, Stefan D. Anker, Kenneth Fearon, Myopenia—a new universal term for muscle wasting Journal of Cachexia, Sarcopenia and Muscle. ,vol. 2, pp. 1- 3 ,(2011) , 10.1007/S13539-011-0025-7
J. E. Morley, Sarcopenia: Diagnosis and treatment Journal of Nutrition Health & Aging. ,vol. 12, pp. 452- 456 ,(2008) , 10.1007/BF02982705
William J. Evans, John E. Morley, Josep Argilés, Connie Bales, Vickie Baracos, Denis Guttridge, Aminah Jatoi, Kamyar Kalantar-Zadeh, Herbert Lochs, Giovanni Mantovani, Daniel Marks, William E. Mitch, Maurizio Muscaritoli, Armine Najand, Piotr Ponikowski, Filippo Rossi Fanelli, Morrie Schambelan, Annemie Schols, Michael Schuster, David Thomas, Robert Wolfe, Stefan D. Anker, Cachexia: a new definition. Clinical Nutrition. ,vol. 27, pp. 793- 799 ,(2008) , 10.1016/J.CLNU.2008.06.013